Back to search
FDAFDA · Food and drugs·Recall number D-845-2013

No Doz, Max Strength (200 mg caffeine) caplets, 2-count caplets per pouch, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 2070 02

Published August 14, 2013 · Recall initiated: June 6, 2013

Summary

FDA records drug Class II recall D-845-2013, published August 14, 2013 and initiated June 6, 2013. Recalling firm: Novartis Consumer Health; Status: Terminated; Reported quantity: 4,422,000 pouches; Lot: Lot #s 10110263, Exp 2/14; 10114706, Exp 4/14; 10118209, Exp 5/14; 10120253, Exp 7/14; 10123520, Exp 8/14; 10095199, Exp 7/13; 10102536, 11/2013, 10103950, Exp 12/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container: products are packaged in pouches which may not have been fully sealed

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Novartis Consumer Health
Distributor
Nationwide, Puerto Rico, Brazil and Panama
Lot
Lot #s 10110263, Exp 2/14; 10114706, Exp 4/14; 10118209, Exp 5/14; 10120253, Exp 7/14; 10123520, Exp 8/14; 10095199, Exp 7/13; 10102536, 11/2013, 10103950, Exp 12/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was No Doz, Max Strength (200 mg caffeine) caplets, 2-count caplets per pouch, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 2070 02 recalled?

Yes. FDA published recall D-845-2013 on August 14, 2013. Reported hazard: Defective container: products are packaged in pouches which may not have been fully sealed

What should I do if I have this product?

Voluntary: Firm initiated · Letter